Rapid infectious disease test Vivalytic

SARS-COV-2coronavirusinfluenza A

The Viral Respiratory Tract Infections (VRI) test offers a rapid and comprehensive solution, capable of detecting 10 different viral respiratory infections, including SARS-CoV-2, within a remarkably short timeframe of 2 hours and 30 minutes. This extensive panel equips healthcare providers with the ability to swiftly identify potential co-infections, thereby enabling them to make more informed treatment decisions for patients grappling with respiratory illnesses. The expedited detection of multiple viruses not only aids in timely intervention but also holds the promise of reducing unnecessary antibiotic usage, consequently leading to improved patient outcomes and more effective management of respiratory conditions. Key Benefits: - Detection of up to 10 viral targets simultaneously from a single patient sample in 2.5 hours - Comprises sarbecovirus as a confirmatory target accurately diagnosing COVID-19 - Target genes in line with WHO & CDC recommendations - Full molecular workflow consolidated into one small benchtop platform - Powered by Randox Biochip Technology enabling multiple results from one patient sample - Easy 4 step process from sample entry to results. No laboratory training required.